For the week, the Dow Jones Industrial Average dropped 1,721 points closing at 25,605.54. The S&P 500 fell 167 points to 3040.31 while the Nasdaq Composite fell 248 points to 9,588.81. The sell-off this week mostly took place on Thursday, the worst day for the market since March, when the news was confirmed about the new cases and hospitalizations.
ETFG Fund Flow Summary - In ETFs, we saw outflows from some of the large geographic-focused ETFs. BBEU, the JPMorgan BetaBuilders Europe ETF, lost over $1.4B in assets during this week. That was followed by BBJP, the JPMorgan BetaBuilders Japan ETF, which shed about $1B in assets. In inflows, we saw investors move their assets to Sector based ETFs. XLF, the Financial Select Sector SPDR ETF, saw some of the greatest inflows for the week, gaining over $3.5B in AUM. That was followed by XLV, the Health Care Select Sector SPDR ETF, which gained over $2.25B in assets.
ETFG Weekly Select List - The five most highly rated ETFs per Sector, Geographic Region and Strategy as ranked by the ETFG Quant model.
Because of this strategy’s success, we highlight some substantial movement in the Health Care portion of this week’s Select List to last. The SPDR S&P Biotech ETF, XBI, held steady at the top spot on the list. Following that was FHLC, the Fidelity MSCI Health Care Index ETF and JHMH, the John Hancock Multifactor Healthcare ETF, which moved up one spot from last week. Rounding out the list this week was BBH, VanEck Vectors Biotech ETF and PPH, VanEck Vectors Pharmaceutical ETF, which finished 4th and 5th on the list respectively.
We will continue to pay close attention to the new data coming out this week on new coronavirus cases. Though many government leaders were urging not to panic over the numbers, the thought of diving fully back into stay-at-home orders will be enough to keep volatility churning in the marketplace.
Thanks for reading ETF Global Perspectives!
ETFG 21 Day Free Trial: https://www.etfg.com/signup/quick
Assumptions, opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. ETF Global LLC (“ETFG”) and its affiliates and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively ETFG Parties) do not guarantee the accuracy, completeness, adequacy or timeliness of any information, including ratings and rankings and are not responsible for errors and omissions or for the results obtained from the use of such information and ETFG Parties shall have no liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of such information. ETFG PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE.
In no event shall ETFG Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of the information contained in this document even if advised of the possibility of such damages.
ETFG ratings and rankings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities or to make any investment decisions. ETFG ratings and rankings should not be relied on when making any investment or other business decision. ETFG’s opinions and analyses do not address the suitability of any security. ETFG does not act as a fiduciary or an investment advisor. While ETFG has obtained information from sources they believe to be reliable, ETFG does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities, financial instruments or strategies mentioned herein may not be suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only correct as of the stated date of their issue. Prices, values, or income from any securities or investments mentioned in this report may fall against the interests of the investor and the investor may get back less than the amount invested. Where an investment is described as being likely to yield income, please note that the amount of income that the investor will receive from such an investment may fluctuate. Where an investment or security is denominated in a different currency to the investor's currency of reference, changes in rates of exchange may have an adverse effect on the value, price or income.
Post a Comment
Note: Only a member of this blog may post a comment.